S. K. Spangler

发表

Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.

M. Jacobs, P. Appelbaum, S. K. Spangler, 1997, The Journal of antimicrobial chemotherapy.

Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci

M. Jacobs, P. Appelbaum, G. Lin, 1997, Antimicrobial agents and chemotherapy.

Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents

M. Jacobs, L. Ednie, P. Appelbaum, 1997, Antimicrobial agents and chemotherapy.

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci

M. Jacobs, P. Appelbaum, S. K. Spangler, 1996, Antimicrobial agents and chemotherapy.

Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci

M. Jacobs, S. Bajaksouzian, L. Ednie, 1996, Antimicrobial agents and chemotherapy.

Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole

M. Jacobs, L. Ednie, P. Appelbaum, 1997, Antimicrobial agents and chemotherapy.

Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin

M. Jacobs, P. Appelbaum, S. K. Spangler, 1994, Antimicrobial Agents and Chemotherapy.

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

M. Jacobs, P. Appelbaum, S. K. Spangler, 1994, Antimicrobial Agents and Chemotherapy.

Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1996, Antimicrobial agents and chemotherapy.

Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.

M. Jacobs, P. Appelbaum, G. Pankuch, 1993, The Journal of antimicrobial chemotherapy.

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin

M. Jacobs, P. Appelbaum, S. K. Spangler, 1992, Antimicrobial Agents and Chemotherapy.

In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1994, Antimicrobial Agents and Chemotherapy.

SUSCEPTIBILITY OF ANAEROBIC BACTERIA TO TROVAFLOXACIN: COMPARISON WITH OTHER QUINOLONES AND NON‐QUINOLONE ANTIBIOTICS

M. Jacobs, P. Appelbaum, S. K. Spangler, 1996 .

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents

M. Jacobs, P. Appelbaum, S. K. Spangler, 1991, Antimicrobial Agents and Chemotherapy.

Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1994, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Cefminox against Anaerobic Bacteria Compared with Those of Nine Other Compounds

P. Appelbaum, D. Hoellman, M. R. Jacobs, 1998, Antimicrobial Agents and Chemotherapy.

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.

M. Jacobs, P. Appelbaum, S. K. Spangler, 1993, The Journal of antimicrobial chemotherapy.

Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology

M. Jacobs, P. Appelbaum, S. K. Spangler, 1997, Antimicrobial agents and chemotherapy.

MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.

M. Jacobs, P. Appelbaum, S. K. Spangler, 1997, Antimicrobial agents and chemotherapy.

Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies

M. Jacobs, P. Appelbaum, S. K. Spangler, 1995, Journal of clinical microbiology.

Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2

P. Appelbaum, S. K. Spangler, 1993, Journal of clinical microbiology.

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

M. Jacobs, P. Appelbaum, M. R. Jacobs, 1994, Antimicrobial Agents and Chemotherapy.

Comparison of the E-test and conventional agar dilution methods for susceptibility testing of gram-negative anaerobic rods.

M. Cohen, M. Jacobs, P. Appelbaum, 1994, Diagnostic microbiology and infectious disease.

Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers

M. Jacobs, P. Appelbaum, S. K. Spangler, 1990, Antimicrobial Agents and Chemotherapy.

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

M. Jacobs, P. Appelbaum, S. K. Spangler, 1986, Antimicrobial Agents and Chemotherapy.

Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents

M. Jacobs, P. Appelbaum, S. K. Spangler, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance

L. Gutmann, A. Philippon, M. Jacobs, 1990, Antimicrobial Agents and Chemotherapy.

Characterization of r-Lactamases from Non-Bacteroides fragilis Group Bacteroides spp. Belonging to SeVen Species and Their Role in r3-Lactam Resistance

A. Philippon, P. Appelbaum, M. R. Jacobs, 2022 .

Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.

L. Sollenberger, P. Appelbaum, S. K. Spangler, 1986, The Journal of antimicrobial chemotherapy.

Comparative activity of the new fluoroquinolone bay y3118 against 177 penicillin susceptible and resistant pneumococci

M. Jacobs, P. Appelbaum, S. K. Spangler, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin

R. Shiman, M. Jacobs, P. Appelbaum, 1992, Antimicrobial Agents and Chemotherapy.

β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres

M. Jacobs, P. Appelbaum, S. K. Spangler, 1990 .

Reduction of oral flora with ciprofloxacin in healthy volunteers.

P. Appelbaum, S. K. Spangler, M. Strauss, 1988, The Journal of antimicrobial chemotherapy.

Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci

M. R. Jacobs, P. Appelbaum, Gengrong Lin, 1998, Antimicrobial Agents and Chemotherapy.

Postantibiotic Effects of Grepafloxacin Compared to Those of Five Other Agents against 12 Gram-Positive and -Negative Bacteria

S. Bajaksouzian, P. Appelbaum, M. R. Jacobs, 2000, Antimicrobial Agents and Chemotherapy.

Characterization of a beta-lactamase from Clostridium clostridioforme.

E. Goldstein, A. Philippon, D. Citron, 1994, Journal of Antimicrobial Chemotherapy.

Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.

M. Jacobs, P. Appelbaum, S. K. Spangler, 1989, The Journal of antimicrobial chemotherapy.

Multiply resistant pneumococci in the Netherlands

Y. Holloway, J. Snijder, J. Schiphuis, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.

M. Jacobs, P. Appelbaum, S. K. Spangler, 1997, The Journal of antimicrobial chemotherapy.

Susceptibility of 170 Penicillin-Susceptible and -Resistant Pneumococci to Various Antimicrobials

M. Jacobs, P. Appelbaum, S. K. Spangler, 2012, Drugs.

Survival of bacteria in Difco CultureSwab and Marion Culturette II transport systems

P. Appelbaum, A. Crist, S. K. Spangler, 1988, Journal of Clinical Microbiology.